Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,443 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

NCT03657043

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Stanford Cancer Center South Bay San Jose, California, United States
  • Poudre Valley Health System (PVHS) Fort Collins, Colorado, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Miami Cancer Institute- Plantation (MCIP) Miami, Florida, United States
View all 37 locations
View Trial Details
Completed

A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer

NCT02737787

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Completed

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

NCT03073525

Conditions
Adnexal Diseases, Advanced Gynecological Cancers, Cervical Cancer, +20 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Billings Clinic Billings, Montana, United States
View Trial Details
Completed

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03038100

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • St. Joseph'S Hospital & Medical Center Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Scottsdale, Arizona, United States
  • Arizona Oncology - HOPE Wilmot Tucson, Arizona, United States
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
View all 268 locations
View Trial Details
Completed

Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

NCT03639246

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Arizona Oncology Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Kaiser Permanente Oakland Oakland, California, United States
  • Kaiser Permanente Roseville Roseville, California, United States
View all 16 locations
View Trial Details

Related conditions